BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36046761)

  • 41. Estimating Venous Thromboembolism Risk in Metastatic Colorectal Cancer Inpatients: Validation of Existing Risk Scores and Development of New Risk Scores.
    Qin L; Liang Z; Xie J; Li X
    Clin Appl Thromb Hemost; 2023; 29():10760296231196859. PubMed ID: 37691565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between systemic immune inflammatory index and prognosis of patients with hepatic alveolar hydatid disease and establishment of a nomogram prediction model.
    Xiaobin C; Jiaqi Y; Zhaojun X; Mingquan P; Ying Z; Lizhao H; Li R; Haijiu W; Zhixin W; Haining F; Lin C
    Front Surg; 2022; 9():1019963. PubMed ID: 36684205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and validation of machine learning models for postoperative venous thromboembolism prediction in colorectal cancer inpatients: a retrospective study.
    Qin L; Liang Z; Xie J; Ye G; Guan P; Huang Y; Li X
    J Gastrointest Oncol; 2023 Feb; 14(1):220-232. PubMed ID: 36915444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and Validation of a Modified Khorana Score for Predicting Venous Thromboembolism in Newly Diagnosed Stage IV Lung Cancer.
    Qin Y; Liang X; Wu H; Sun X; Yan S; Wang N; Yuan M; Wang Q; Wu D
    Angiology; 2023 Nov; ():33197231213197. PubMed ID: 37924222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
    Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
    J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive value of inflammatory and coagulation biomarkers for venous thromboembolism in COVID-19 patients.
    Hojker M; Tršan J; Tršan U; Gale A; Jerman A; Košuta D
    Clin Hemorheol Microcirc; 2023; 83(4):387-395. PubMed ID: 36683498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the risk of venous thromboembolism in patients with haematological cancers using three prediction models.
    El-Sayed HA; Othman M; Azzam H; Bucciol R; Ebrahim MA; El-Agdar MAMA; Tera Y; Sakr DH; Ghoneim HR; Selim TE
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17771-17780. PubMed ID: 37935936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nomogram model combined thrombelastography for venous thromboembolism risk in patients undergoing lung cancer surgery.
    Qin D; Cai H; Liu Q; Lu T; Tang Z; Shang Y; Cui Y; Wang R
    Front Physiol; 2023; 14():1242132. PubMed ID: 38162832
    [No Abstract]   [Full Text] [Related]  

  • 49. Risk factors associated with venous thromboembolism in tuberculosis: A case control study.
    Nan GY; Fei H; Zhen W; Yun DT
    Clin Respir J; 2022 Dec; 16(12):835-841. PubMed ID: 36344481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients.
    Akasaka-Kihara F; Sueta D; Ishii M; Maki Y; Hirakawa K; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Hanatani S; Kanazawa H; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Kaikita K; Matsushita K; Matsuoka M; Usuku K; Tsujita K
    JACC Asia; 2021 Sep; 1(2):259-270. PubMed ID: 36338156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
    Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
    J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
    Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Newman P; Mortazavi R
    Thromb Res; 2024 Feb; 234():120-133. PubMed ID: 38215613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
    Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
    Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of the RCOG Risk Assessment Model for Evaluating Postpartum Venous Thromboembolism in Chinese Women: A Case-Control Study.
    Ge YZ; Zhang C; Cai YQ; Huang HF
    Med Sci Monit; 2021 Jul; 27():e929904. PubMed ID: 34230447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.
    Cella CA; Di Minno G; Carlomagno C; Arcopinto M; Cerbone AM; Matano E; Tufano A; Lordick F; De Simone B; Muehlberg KS; Bruzzese D; Attademo L; Arturo C; Sodano M; Moretto R; La Fata E; De Placido S
    Oncologist; 2017 May; 22(5):601-608. PubMed ID: 28424324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors.
    Wang L; Wei S; Zhou B; Wu S
    Thromb Res; 2021 Jun; 202():52-58. PubMed ID: 33735691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Value of Systemic Immune-Inflammation Index-Based Nomogram in Patients with Extrahepatic Cholangiocarcinoma Treated by Percutaneous Transhepatic Biliary Stenting Combined with
    Yang J; Shu C; Shang X; Xu H; Wei N
    Int J Gen Med; 2023; 16():2081-2094. PubMed ID: 37275332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Nomogram for Predicting Venous Thromboembolism in Critically Ill Patients with Primary Intracerebral Hemorrhage.
    Liu S; Wang Y; Gao B; Peng J
    World Neurosurg; 2022 Jan; 157():e301-e307. PubMed ID: 34648989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.